Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000057029 |
|---|---|
| Receipt number | R000065185 |
| Scientific Title | Examination of optimal patient endpoints in developing new therapeutic drugs for symptomatic bradycardia. |
| Date of disclosure of the study information | 2025/04/01 |
| Last modified on | 2026/02/09 20:25:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2025/02/14 14:34:46 | ||
| 2 | Update | 2025/02/14 14:35:49 | UMIN ID1 |
|
| 3 | Update | 2025/02/14 14:36:19 | UMIN ID2 |
|
| 4 | Update | 2025/04/02 16:23:25 | Name of primary person or sponsor Institute |
|
| 5 | Update | 2026/01/26 10:12:31 | Key inclusion criteria Key exclusion criteria |
|
| 6 | Update | 2026/01/26 10:14:47 | Key exclusion criteria |
|
| 7 | Update | 2026/02/09 20:19:54 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 8 | Update | 2026/02/09 20:25:39 | Acronym Scientific Title:Acronym |